Impact News +++ Why Confluent Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket (Benzinga) +++ CONFLUENT Aktie -3,03%

SMITH & NEPHEW Aktie

>SMITH & NEPHEW Aktienkurs

14.75 EUR +2.2% (Tradegate)

Ask: 14.825 EUR / 400 Stück

Bid: 14.6 EUR / 400 Stück

Tagesumsatz: 1529 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

SMITHNEPHEW Aktie über LYNX handeln

Intraday

1 Jahr

>SMITH & NEPHEW Performance

1 Woche: -1,2%

1 Monat: -10,6%

3 Monate: -12,5%

6 Monate: +10,2%

1 Jahr: +22,2%

laufendes Jahr: +21,0%

>SMITH & NEPHEW Aktie

Name:

SMITH & NEPHEW

Land:

Großbritannien

Sektor:

Gesundheit

ISIN/ Wkn:

GB0009223206 / 502816

Symbol/ Ticker:

NPW1 (Frankfurt)

Kürzel:

FRA:NPW1, ETR:NPW1, NPW1:GR

Index:

FTSE100

Webseite:

https://www.smith-nephew...

Profil:

Smith & Nephew plc is a leading global medical tec..
>Volltext..

Marktkapitalisierung:

12288.41 Mio. EUR

Unternehmenswert:

14651.17 Mio. EUR

Umsatz:

5417.85 Mio. EUR

EBITDA:

1416.74 Mio. EUR

Nettogewinn:

447.34 Mio. EUR

Gewinn je Aktie:

0.51 EUR

Schulden:

2972.24 Mio. EUR

Liquide Mittel:

581.71 Mio. EUR

Operativer Cashflow:

1039.9 Mio. EUR

Bargeldquote:

0.44

Umsatzwachstum:

1.21%

Gewinnwachstum:

54.88%

Dividende je Aktie:

0.33 EUR

Dividendenrendite:

2.29%

Dividendenschätzung:

2.33%

Div. Historie:

02.10.25 - 0.1287€
27.03.25 - 0.198198€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

SMITH & NEPHEW, SMITHNEPHEW, SMITH NEPHEW, SMITH&NEPHEW

Letzte Datenerhebung:

08.12.25

>SMITHNEPHEW Kennzahlen

Aktien/ Unternehmen:

Aktien: 847.81 Mio. St.

Frei handelbar: 97.61%

Leerverk. Aktien: 3.3%

Rückkaufquote: -0.01%

Mitarbeiter: 18456

Umsatz/Mitarb.: 0.26 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 15.08%

Bewertung:

KGV: 28.13

KGV lG: 16.6

KUV: 2.37

KBV: 2.62

PEG-Ratio: 0.52

EV/EBITDA: 10.34

Rentabilität:

Bruttomarge: 70.04%

Gewinnmarge: 8.26%

Operative Marge: 15.29%

Managementeffizenz:

Gesamtkaprendite: 4.7%

Eigenkaprendite: 9.3%

>SMITHNEPHEW Anleihen

Es sind 1 Anleihen zur SMITH & NEPHEW Aktie bekannt.

>SMITHNEPHEW Peer Group

Es sind 82 Aktien bekannt.

>SMITH & NEPHEW Chart & Kurs - Tradegate

>SMITH & NEPHEW News

08.12.25 - 12:12	Smith & Nephew guides growth out to 2028 as set to meet target in 2025 (Alliance)
	Smith & Nephew PLC on Monday announced targets for 2028, aiming for revenue and profit growth, as it is set to meet its goals...

08.12.25 - 12:00	Smith & Nephew boosts guidance as it unveils new strategy (ShareCast)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

08.12.25 - 10:06	FTSE 100 today: Index up, pound dips; Magnum debuts, Smith & Nephew sets new goals (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

08.12.25 - 09:27	Smith+Nephew sets ambitious growth targets through 2028 (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

08.12.25 - 09:24	Smith & Nephew Says On Track For 2025 Targets, Unveils New Strategy And 2028 Goals (AFX)
	LONDON (dpa-AFX) - Smith & Nephew Plc (SNN), a medical technology company, on Monday said it remains on track to meet its 2025 performance targets as it outlined a new strategic plan, updated 2026......

08.12.25 - 04:36	Ihre wichtigsten Termine: Alle Augen auf: Stabilus, Smith & Nephew sowie Konjunkturdaten aus China & Japan (Wallstreet-Online)
	Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag....

03.12.25 - 14:33	Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion (PR Newswire)
	NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the appointment of Mark Saxton as Chief Executive Officer of its U.S.......

10.11.25 - 07:12	Should investors consider buying last week′s FTSE 100 losers IAG, Rightmove, and Smith & Nephew? (Fool)
	These three FTSE 100 names tanked last week. Could the share price weakness have created opportunities for patient long-term investors? The post Should investors consider buying last week's FTSE 100 losers IAG, Rightmove, and Smith & Nephew? appeared first on The Motley Fool UK....

06.11.25 - 21:24	Smith & Nephew Q3 revenues grow, raises FCF guidance (ShareCast)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

06.11.25 - 12:36	Health Care Roundup: Market Talk (WSJ EN)
	Find insight on AstraZeneca, Smith & Nephew, Novo Nordisk and more in the latest Market Talks covering Health Care....

06.11.25 - 12:30	Health Care Roundup: Market Talk (WSJ EN)
	Find insight on AstraZeneca, Smith & Nephew, Novo Nordisk and more in the latest Market Talks covering Health Care....

06.11.25 - 10:12	Smith & Nephew shares fall as third quarter sales miss consensus (Alliance)
	Smith & Nephew PLC on Thursday raised its annual free cash flow outlook, but shares slumped as third quarter revenue fell...

06.11.25 - 09:42	Smith+Nephew shares tumble as Q3 sales miss expectations (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

27.10.25 - 16:33	Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT (GlobeNewswire EN)
	Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices in orthopedic and cardiovascular surgery....

22.10.25 - 17:33	UFC® and Smith+Nephew announce multi-year extension of partnership (GlobeNewswire EN)
	Smith+Nephew to continue as UFC's Preferred Sports Medicine Technology Partner...

16.10.25 - 08:54	Sectra adds Smith+Nephew 3D templates to its orthopaedic solution--supporting wider adoption of digital surgical planning (PR Newswire)
	LINKÖPING, Sweden, Oct. 16, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra(STO: SECT B) has expanded its pre-operative planning solution for orthopaedic trauma cases with 3D templates from one of the world's leading medical equipment companies,......

16.10.25 - 08:36

Sectra adds Smith+Nephew 3D templates to its orthopaedic solution—supporting wider adoption of digital surgical planning (Cision)

Linköping, Sweden – October 16, 2025 – International medical imaging IT and cybersecurity company Sectra (https://sectra.com/) (STO: SECT B) has expanded its pre-operative planning solution for orthopaedic trauma cases with 3D templates from one of the world's leading medical equipment companies, Smith+Nephew. Extending the range of templates in Sectra's solution supports a broader adoption of digital pre-operative planning, a key enabler of patient-specific treatments, which improves operational efficiency and patient outcomes. Paul Tornetta III, MD, Director of orthopaedic trauma at Boston...

09.10.25 - 18:33	Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant (GlobeNewswire EN)
	Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT) code for procedures involving its CARTIHEAL AGILI-C Cartilage Repair Implant, effective January 1, 2027. ...

03.10.25 - 17:57	Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention (GlobeNewswire EN)
	Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce exciting new data from Professor Amit Gefen and his research group published in the International Wound Journal,1 demonstrating the pressure injury prevention mechanism of action of ALLEVYN COMPLETE CARE Foam Dressing and its ability to absorb and dissipate friction and shear forces....

02.10.25 - 23:12	Moody′s bestätigt Rating für Smith & Nephew und hebt Ausblick auf "positiv" an (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wer der Folter erlag, kann nicht mehr heimisch werden auf dieser Welt. - Jean Améry

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram